Kanawha Capital Management LLC Sells 52 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Kanawha Capital Management LLC trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 10.0% in the fourth quarter, Holdings Channel.com reports. The firm owned 467 shares of the medical equipment provider’s stock after selling 52 shares during the quarter. Kanawha Capital Management LLC’s holdings in Intuitive Surgical were worth $244,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of ISRG. Berbice Capital Management LLC bought a new stake in Intuitive Surgical during the 4th quarter worth approximately $26,000. Godsey & Gibb Inc. increased its stake in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical during the 3rd quarter worth approximately $33,000. Decker Retirement Planning Inc. bought a new stake in Intuitive Surgical during the 4th quarter worth approximately $36,000. Finally, Capital Performance Advisors LLP bought a new stake in Intuitive Surgical during the 3rd quarter worth approximately $38,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $595.55 on Friday. The business has a fifty day simple moving average of $558.58 and a two-hundred day simple moving average of $518.00. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The company has a market capitalization of $212.12 billion, a price-to-earnings ratio of 92.91, a P/E/G ratio of 5.67 and a beta of 1.39.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on ISRG. Evercore ISI increased their target price on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a research report on Friday, October 18th. CICC Research began coverage on Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 price target for the company. BTIG Research upped their price target on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of the stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now owns 8,757 shares in the company, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 6,348 shares of company stock valued at $3,587,582 in the last quarter. 0.90% of the stock is currently owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.